相关实验视频

Updated: Jun 6, 2025

Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation

Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation

Published on: June 26, 2018

SMOC1与阿尔茨海默病的神经病理学共定位,并延迟了Aβ聚合

Kaleah Balcomb¹, Caitlin Johnston², Tomas Kavanagh¹

¹Brain and Mind Centre and School of Medical Sciences, University of Sydney, Camperdown, NSW, 2050, Australia.

Acta neuropathologica

|November 25, 2024

概括

分泌的模块连接组织蛋白1 (SMOC1) 是早期阿尔茨海默病 (AD) 的生物标志物. 这项研究发现SMOC1与粉样β和tau相互作用,可能影响AD病理的发展.

科学领域:

神经科学是一个神经科学.
生物化学生物化学
病理学病理学病理学

背景情况:

分泌的模块连接组织蛋白1 (SMOC1) 是一种新的阿尔茨海默病 (AD) 生物标志物.
大脑脊髓液中SMOC1水平升高在AD症状出现之前.
在AD病变发生过程中SMOC1的确切作用和大脑功能在很大程度上仍未被探索.

研究的目的:

为了研究SMOC1在人类AD脑组织中的分布,跨越不同疾病阶段.
为了确定SMOC1与粉样蛋白β (Aβ) 和酸化的相互作用.
评估SMOC1对Aβ聚合动力学和纤维细胞形态学的影响.

主要方法:

73个人类大脑样本中的免疫组织化学 (AD,MCI,临床前AD,对照).
同免疫沉分析蛋白质相互作用.
提奥夫拉-T测定和电子显微镜用于研究Aβ聚合.

主要成果:

在AD,MCI和临床前AD脑组织中,SMOC1与粉样斑块和酸化聚合物结合.
与斑块负荷相关的SMOC1水平,独立于疾病阶段.
SMOC1显著延迟了Aβ聚合,并以剂量依赖的方式改变了纤维细胞形态.

结论:

SMOC1与AD神经病理密切相关,包括粉样斑块和团.
SMOC1与关键的AD病理蛋白Aβ和tau相互作用.
通过抑制Aβ聚合,SMOC1可能发挥保护作用,这表明它在AD进展中起着复杂的作用.

关键词:

阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.贝塔氨基化物贝塔氨基化物电子显微镜的电子显微镜免疫组织化学免疫组织化学轻度认知障碍轻度认知障碍标签: 牌子标签: 牌子临床前临床前在SMOC1上.纠结的纠结纠结的纠结塔乌塔乌 (Tau Tau) 是一个提奥夫拉文T 提奥夫拉文T

更多相关视频

Detection of Neuritic Plaques in Alzheimer's Disease Mouse Model

Detection of Neuritic Plaques in Alzheimer's Disease Mouse Model

Published on: July 26, 2011

Correlative Light and Electron Microscopy to Study Microglial Interactions with β-Amyloid Plaques

Correlative Light and Electron Microscopy to Study Microglial Interactions with β-Amyloid Plaques

Published on: June 1, 2016

相关概念视频

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Amyloid Fibrils

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...